Sastre, J., Maestro, M. L., Gómez-España, A., Rivera, F., Valladares, M., Massuti, B., . . . Díaz-Rubio, E. (2012). Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study. AlphaMed Press.
Chicago Style CitationSastre, Javier, et al. Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study. AlphaMed Press, 2012.
Cita MLASastre, Javier, et al. Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study. AlphaMed Press, 2012.